Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other hematologic neoplasm 3Myeloid 3CNS 3Other neoplasm 2Lymphoid 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 1454Pancreatic Neoplasms 830Stomach Neoplasms 691Carcinoma, Hepatocellular 645Carcinoma, Non-Small-Cell Lung 537Neoplasms 457Breast Neoplasms 368Ovarian Neoplasms 336Neoplasm Metastasis 333Colonic Neoplasms 330Esophageal Neoplasms 296Liver Neoplasms 265Melanoma 255Lung Neoplasms 245Squamous Cell Carcinoma of Head and Neck 208Cholangiocarcinoma 179Carcinoma, Renal Cell 178Prostatic Neoplasms 173Head and Neck Neoplasms 172Triple Negative Breast Neoplasms 160Rectal Neoplasms 158Endometrial Neoplasms 158Uterine Cervical Neoplasms 153Gastrointestinal Neoplasms 142Urinary Bladder Neoplasms 139Biliary Tract Neoplasms 134Gastrointestinal Stromal Tumors 107Sarcoma 104Esophageal Squamous Cell Carcinoma 100Small Cell Lung Carcinoma 92

Interventions

ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pathologic Processes × Gastrointestinal × Clear all
NCT00969410 2012-04-12

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

AVEO Pharmaceuticals, Inc.

Phase 1 Completed
19 enrolled
Gastrointestinal

Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡